Building on the Legacy of Vaccines in Canada
Building on the Legacy of Vaccines In Canada: Value, Opportunities, and Challenges
Spearheaded by BIOTECanada’s Vaccine Industry Committee (VIC), and compiled with contributions from experts in the vaccine field, Building on the Legacy of Vaccines in Canada: Value, Opportunities, and Challenges provides a unique analysis of Canada’s vaccine environment, highlighting the tremendous medical, social and economic value of vaccines.
The series presents an in-depth discussion of the opportunities and challenges across the entire vaccine development chain in Canada, from early-stage and clinical research and through to vaccine licensure, and recommends national approaches all key stakeholders can implement to help Canada maintain its leadership position in global public health immunization programs.
Read the Series here.
Spearheaded by BIOTECanada’s Vaccine Industry Committee (VIC), and compiled with contributions from experts in the vaccine field, Building on the Legacy of Vaccines in Canada: Value, Opportunities, and Challenges provides a unique analysis of Canada’s vaccine environment, highlighting the tremendous medical, social and economic value of vaccines.
The series presents an in-depth discussion of the opportunities and challenges across the entire vaccine development chain in Canada, from early-stage and clinical research and through to vaccine licensure, and recommends national approaches all key stakeholders can implement to help Canada maintain its leadership position in global public health immunization programs.
Read the Series here.
Join the Dialogue
